Pathophysiology of Hypoxemia in COVID-19 Lung Disease
- PMID: 37085217
- PMCID: PMC9682047
- DOI: 10.1016/j.ccm.2022.11.007
Pathophysiology of Hypoxemia in COVID-19 Lung Disease
Abstract
As the pandemic has progressed, our understanding of hypoxemia in coronavirus disease 2019 (COVID-19) lung disease has become more nuanced, although much remains to be understood. In this article, we review ventilation-perfusion mismatching in COVID-19 and the evidence to support various biologic theories offered in explanation. In addition, the relationship between hypoxemia and other features of severe COVID-19 lung disease such as respiratory symptoms, radiographic abnormalities, and pulmonary mechanics is explored. Recognizing and understanding hypoxemia in COVID-19 lung disease remains essential for risk stratification, prognostication, and choice of appropriate treatments in severe COVID-19.
Keywords: ARDS; COVID-19; Hypoxemia; SARS-CoV-2.
Copyright © 2022 Elsevier Inc. All rights reserved.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
